Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Acacia Pharma Group plc (BR: ACPH)

 
ACPH Technical Analysis
5
As on 8th Jun 2022 ACPH SHARE Price closed @ 0.89 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.31 & Strong Sell for SHORT-TERM with Stoploss of 2.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACPHSHARE Price

Open 0.88 Change Price %
High 0.89 1 Day 0.00 0.00
Low 0.88 1 Week 0.03 3.49
Close 0.89 1 Month 0.09 11.25
Volume 761376 1 Year -2.08 -70.03
52 Week High 3.37 | 52 Week Low 0.74
 
BR Belgium Most Active Stocks
BOTHE 0.29 70.59%
ABI 50.92 0.47%
ACPH 0.89 0.00%
KBC 66.02 2.36%
UMI 26.30 2.94%
PROX 7.06 0.14%
OPTI 0.02 %
BPOST 4.33 3.10%
WDP 26.58 1.22%
EURN 14.06 2.33%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
UPG 3.84 14.97%
QRF 10.20 3.66%
MOUR 352.00 3.53%
ANT 6.41 3.22%
ANT 6.41 3.22%
HYL 11.30 3.20%
ZEN 198.00 3.12%
ZEN 198.00 3.12%
ZEN 198.00 3.12%
 
BR Belgium Top Losers Stocks
BELR 1.93 -74.27%
BELR 1.93 -74.27%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
ECONB 2.56 -3.40%
BCART 0.35 -2.78%
BEFB 46.10 -2.54%
 
 
ACPH
Daily Charts		 ACPH
Intraday Charts		 Whats New @
Bazaartrend		 ACPH
Free Analysis
 
ACPH Important Levels Intraday
RESISTANCE0.91
RESISTANCE0.90
RESISTANCE0.90
RESISTANCE0.90
SUPPORT0.88
SUPPORT0.88
SUPPORT0.88
SUPPORT0.87
 
ACPH Forecast April 2024
Share
4th UP Forecast2.32
3rd UP Forecast1.86
2nd UP Forecast1.58
1st UP Forecast1.29
1st DOWN Forecast0.49
2nd DOWN Forecast0.2
3rd DOWN Forecast-0.08
4th DOWN Forecast-0.54
 
ACPH Weekly Forecast
4th UP Forecast1.20
3rd UP Forecast1.10
2nd UP Forecast1.04
1st UP Forecast0.98
1st DOWN Forecast0.80
2nd DOWN Forecast0.74
3rd DOWN Forecast0.68
4th DOWN Forecast0.58
 
ACPH Forecast2024
4th UP Forecast6.19
3rd UP Forecast4.49
2nd UP Forecast3.44
1st UP Forecast2.39
1st DOWN Forecast-0.61
2nd DOWN Forecast-1.66
3rd DOWN Forecast-2.71
4th DOWN Forecast-4.41
 
 
ACPH Other Details
Segment EQ
Market Capital 168117808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACPH Address
ACPH
 
ACPH Latest News
 
Your Comments and Response on Acacia Pharma Group plc
 
ACPH Business Profile
Acacia Pharma Group plc, a hospital pharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, other invasive procedures, or cancer chemotherapy treatments in the United States and internationally. The company's lead product is BARHEMSYS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting. Its products also include BYFAVO, an ultra-short-acting and reversible intravenous sedative benzodiazepine for the use in invasive medical procedures, such as bronchoscopies and colonoscopies; and APD403, an intravenous and oral amisulpride that has completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting. The company's products are primarily serves anesthesiologists and oncologists. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom. Address: The Officers? Mess, Cambridge, United Kingdom, CB22 4QH
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service